Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 6/20 | 0.62 |
| ▸ | CES1 | P23141 | 6/20 | 0.62 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2293145 | 0.94 | CES2 (0.55) | CES2CES1HCAR1CA12CA1 | |
| SCHEMBL5223999 | 0.85 | CES2 (0.46) | CES2CES1HCAR1GRM5 | |
| SCHEMBL29558481 | 0.85 | CES2 (0.46) | CES2CES1HCAR1GRM5 | |
| SCHEMBL5225361 | 0.84 | CES2 (0.44) | CES2CES1HCAR1SLC6A3HCAR2 | |
| SCHEMBL15935951 | 0.84 | CES2 (0.44) | CES2CES1HCAR1SLC6A3HCAR2 | |
| SCHEMBL31327392 | 0.84 | CES2 (0.44) | CES2CES1HCAR1SLC6A3HCAR2 | |
| SCHEMBL679313 | 0.80 | CES2 (0.52) | CES2CES1HDAC1HDAC6 | |
| SCHEMBL29593993 | 0.80 | CES2 (0.52) | CES2CES1HDAC1HDAC6 | |
| SCHEMBL3612973 | 0.79 | NPC1 (0.45) | CES2CES1PARP1ALDH1A1NPC1 | |
| SCHEMBL5222697 | 0.79 | CES2 (0.45) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 852 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297056-A1 | METHOD FOR PRODUCING POLYETHERKETONEKETONE | ARKEMA FRANCE (FR) | 2025-09-25 | — | — | US | claimed |
| EP-4519341-A1 | METHOD FOR PRODUCING POLYETHERKETONEKETONE | ARKEMA FRANCE (FR) | 2025-03-12 | — | — | EP | claimed |
| CN-119487101-A | Method for producing polyetherketoneketone | 阿科玛法国公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024250573-A1 | REVERSE OSMOSIS MEMBRANE PREPARATION METHOD AND REVERSE OSMOSIS MEMBRANE PREPARED THEREBY | 沃顿科技股份有限公司 | 2024-12-12 | — | — | WO | claimed |
| CN-119098067-A | Method for producing reverse osmosis membrane and reverse osmosis membrane produced thereby | 沃顿科技股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118994606-A | Lithium battery negative electrode binder and preparation method and application thereof | 艾迪天目(常州)新材料科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117123191-A | For CO 2 Adsorbed resin and preparation method thereof | 中国科学院广州能源研究所 | 2023-11-28 | — | — | CN | claimed |
| CN-117105897-A | HNO donor compound and preparation method thereof | 海南大学 | 2023-11-24 | — | — | CN | claimed |
| CN-117105826-A | HNO-releasable compound and preparation method thereof | 海南大学 | 2023-11-24 | — | — | CN | claimed |
| WO-2023214052-A1 | METHOD FOR PRODUCING POLYETHERKETONEKETONE | ARKEMA FRANCE (FR) | 2023-11-09 | — | — | WO | claimed |
| CN-113773264-A | Pyrimidine amide compound applied to herbicide and preparation method thereof | 池州飞昊达化工有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-103487455-B | A kind of method of hydroxy-containing compounds in Quantitative detection olive oil | SHANGHAI UNIVERSITY (CN) | 2016-04-27 | — | — | CN | claimed |
| CN-103487455-A | Novel method for quick quantitative determination of hydroxy components in olive oil | UNIV SHANGHAI | 2014-01-01 | — | — | CN | claimed |
| CN-1785993-B | Preparation and use of non-natural isocoumarin derivatives | UNIV NANKAI | 2012-03-14 | — | — | CN | claimed |
| US-6803484-B2 | Sulfonamide derivatives | ELI LILLY AND COMPANY | 2004-10-12 | — | — | US | claimed |
| US-20040143020-A1 | Sulfonamide derivatives | AIKINS JAMES ABRAHAM (US) | 2004-07-22 | — | — | US | claimed |
| US-6720357-B2 | TREATMENT OF CONDITIONS ASSOCIATED WITH GLUTAMATE HYPOFUNCTION, SUCH AS PSYCHIATRIC AND NEUROLOGICAL DISORDERS; N-2-(4-N-(3,5-DIFLUOROBENZAMIDO)PHENYL)PROPYL-2-PROPANESULFONAMIDE | ELI LILLY AND COMPANY | 2004-04-13 | — | — | US | claimed |
| US-20030233015-A1 | Sulfonamide derivatives | ELI LILLY AND COMPANY | 2003-12-18 | — | — | US | claimed |
| EP-1296944-A1 | SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2003-04-02 | — | — | EP | claimed |
| WO-2001090056-A1 | SULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2001-11-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030233015-A1 | Sulfonamide derivatives | GRIN2A, GRIN1, SLC1A2 | CES2 532/4885CES1 1233/4885HCAR1 855/4885 |
| US-20040143020-A1 | Sulfonamide derivatives | GRIN2A, GRIN2B, SLC1A2 | CES2 510/4885CES1 1912/4885HCAR1 1019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.